Trends in pre- and post-transplant therapies with first autologous hematopoietic cell transplantation among patients with multiple myeloma in the United States, 2004-2014. Leukemia 2017 Sep;31(9):1998-2000
Date
07/01/2017Pubmed ID
28663578Pubmed Central ID
PMC5587375DOI
10.1038/leu.2017.185Scopus ID
2-s2.0-85028872119 (requires institutional sign-in at Scopus site) 13 CitationsAuthor List
D'Souza A, Zhang MJ, Huang J, Fei M, Pasquini M, Hamadani M, Hari PAuthors
Anita D'Souza MD Associate Professor in the Medicine department at Medical College of WisconsinMehdi H. Hamadani MD Professor in the Medicine department at Medical College of Wisconsin
Parameswaran Hari MD Adjunct Professor in the Medicine department at Medical College of Wisconsin
Marcelo C. Pasquini MD, MS Professor in the Medicine department at Medical College of Wisconsin
Mei-Jie Zhang PhD Professor in the Institute for Health and Equity department at Medical College of Wisconsin
MESH terms used to index this publication - Major topics in bold
AgedAntineoplastic Combined Chemotherapy Protocols
Female
Hematopoietic Stem Cell Transplantation
Humans
Induction Chemotherapy
Male
Middle Aged
Multiple Myeloma
Survival Analysis
Transplantation Conditioning
Transplantation, Autologous
United States